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By letter of L2 February 1980 the Council of the EuroPean
t/ 
co^ unities requested the European Parliament to deriver an opinion on
the proposal from the commission of the European communities to the
Council (Doc. L-750/7g) for a multiannual Community Progralnme of research
and development in biomolecular engineering (indirect action 1981-1985)'
The president of the European Parliament referred this proposal to
the committee on Energy and Research as the committee resPonsible, aod
to the committee on Budgets, the committee on Economic and Monetary
Affairs and the Committee on the Environment, PubIic IIealth and Consumer
Protection for their oPinions.
on 21 February 1980 the Committee on Energy and Research appointed
Mr Sclrmid raPPorteur.
It considered the rePort at its meeting of 23 september 1980 and
adopted the motion for a resolution unanimously'
present: Mrs waIz, chairman; Mr Gallagher, l{r rppolito and
IvIr Normanton, vice-chairmen; Mr Schmid, rapporteur; Mr Adam, Mr BeazIey,
Mrs Bonino, Mr Calvez (deputizing for Mr Pintat), !1r Croux, Mrs Dekker
(deputizing f or Irlr capanna ) , Mr Hof fmann (dePutizing f or Mr Fuchs ) ,
Mr KeIlett-Bowman (depLrtizing f or Mr Seligman), t'lr Linkohr, Mr Morelarrd
(deputizing for sir Peter vanneck), Mr Mi.llIer-Hermann, Mr Price,
Mr purvis, I,lr Rinsche, Mr sdlzer, Mr sassano and t'lr veronesi.
The opinions of the committee on Budgets, the committee on the
Environment, Public Health and Consumer Protection and the Committee on
Economic and Monetary Affairs are attached.
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The Committee on Energy and Regearch hereby submits to the European
parliament the following motion for a resolution, together wlth explanatory
statement:
r,rQrIoN FoE jl RESOLUTTON
embodying the opinion of the European Parliameot on the proposal from the
Commiseion of the European Comrnunities to the Council for a multiaonual
Community programme of research and development io biomolecular engineering
(indirect action 1981-1985)
@,
- having regard to the proposal frrxr the commission of the European
Cornmunitiea to the Council (COM(79) 793 f j.na1),
- having been coneulted by the Council (Doc. L-75O/79\,
- having regard to the opinion of the Economic and Social Committee
'I(cES 5ssl80)',
- having regard to the report by Mr N. RALFOUR on the communication frorn
the Commiesion to the Council concerning convergence and budgetary
questione (Doc. 1-135/80),
- 
having regard to the draf,t council recommendation concerning the
registration of recombinant DNA (deoxyribonucleic acid) work
(poc. L-448/8o\ , 
-- 
-'
.havinqrcaardtoLherePortoftheComtniEceeonEnerqvandReeearctrand
tlre oSriniorrs of t,he conrmitt('c on lludgeLs, the conrmi-ttee on the Environment'
publrc lteaIEh and Consltmer Protection and the Corunittee on Economic and
HonetarY Affairg (Doc. 1-52Il80)'
1. Recognizes the poseible value of the application of molecular biology in
industry and agriculture but drawa attentlon to the conjectural risks of
genetlc engtneering;
2. Recogrnizee that increaeed reaetrch in t'hiE field brings cloEer the poesi-
bility of, manipu).ating human gones and demande an early discussion of the
conseguenceg thereof;
I o,: oto. c 230, 8.9,1980, p.1I
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3. Consider8 that it would be ugeful to have a com$unity resetrch programme
in the field of biotcchnology a8 an indlrect action with a view to:
- the future poeition of Europe on the world market'
- cloeing the gap betwcen the varying levels of econonic develolment in
the !,iember States of the Cotmunity,
- 
the contribution of a research programne to the harmonization of safety
giuidelines for recornbinant DNA work'
- 
the gocial demand for the medical application of biotechnology;
4. Demands however that by 1983 the Comnission should clearly establish the
economic and social demand and the eocial effects of the increaaed use of
biotechnology;
5. Calls on the conmlgelon to tightcn up the prograntnG, definc clear goals
and in so doing enaures
(a)thatnoprojecteareselectedwhichhavealreadybeenthesubjectof
intenaiveworkintheUsAorJapaninordertoavoldunnecegaary
duPlication of work'
(b) that practical projects are selected aimed at:
- Iowerlng productlon coete in agrteulture'
-loweringenergyconaumptioninthechemicalindugtry'
- solving envlronmcntal Problens'
- eolving medical Problema'
- ueing agriculturtl waste Products'
- the biological exploitation of eolar energy'
- more baaic reeearch to aBsGaE the aafcty problerna ralccd by work
wlth recombinant DNA and particularry with regard to ite practical
appllcationa i
6.Demandgthatonlyonethirdofthencnbcrgoftheadvisorycomrtittee
should be appointed by the goverrunents of the l,ternbcr Statce with tuo
thlrds being appointed by the Conmieeion;
T.Stressesthattheadvisorycommitteemustincludehlghlyqurllficd
ecientists in order to guarantee a critical choice;
8. Expects the Commission in implenentlng the progranne to:
-publishinvitat.ion8totenderfortheprojectsnotonlyintheOfficial
,fournal but also in technical publications'
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9.
put Lhe re8eareh unrts together in such a way that the proportion of
ecientiste to technicrane corresponde to condltions prevailing in prac-
tice,
provide finante also for materials (chemicals, etc.),
pursue a prudent information poricy having regard to the aime of the
progralnme and the comPetitive situation both on thc world market and
within Europe,
carry out strict and continuous progranme monitoring with the participa-
tion of scientific experts,
Iink the provision of funds to the observance of the appropriate national
safety gruidelines when concluding contracts on research with recombinant
DNA,
demand obsentance of the strictOet rule where the llember Statee, safety
guidelines for certain experiments differ widely;
Demands that in nagotiations for rescarch contracts the Commisaion:
- shall not deviate from tho principlcs lald dmn in Documont XII-I05,27G
to the detriment of the Community,
ensures that the corununity has a say in the exproitation of patents,
provides for the repalment of research coste where the contractor
patents results obtained with community money and the commission doee
not wish to exerciee influence over their exploltation;
10- States thatttreenew A posts are necessary for the implementation of the
Progralnme and expeets the remaining posts to be recruited from the staff;
Demands the opening of the conciliation proccdure should the council again
intend to encroach upon the budgetary povrers of the European parliament
by fixing appropriations and ;rcats for the duration of the reaearch pro-
gratnme in the text of the regulation and in the event of this legitimate
requeet being ignored would flnd itself under certain circumstances
compelred to freeze all the appropriatione earmarked in the budget for
thie purpose;
Approves the commission's protrrcsar subject to these amendments.
11
L2
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BExplanatorv statement
Molecu1ar bioloqv and its possible uses
1. In the field of nuclear energy the essential implications and concepts
are by now familiar to the layman. This is however not yet true of molecular
biology and its technical application. If it is to be fully understood, the
Commission's proposal for a research programme therefore requires some
introduction.
2. It was unavoidable that the proposal itself should be formulated in
technical language. But in future the Commission should in such cases auto-
ratically supply Parliament with a readable introduction. rt is hard to see
why Parliament should be treated worse than the press, which the Commission
immediately provided with a more readily comprehensible description of the
Programme.
Biotechnoloqv in the past
3. The principle of using the metabolism of microorganisms (bacteria, yeasts,
moulds, etc.) to obtain useful products is well established. At a very early
stage microorganisms were being used - although no one hras aware of their
existence - to make vinegar, beer, leavened bread, curdled milk products,
cheese and alcohol. The breeding of better plant and aninal varieties grew
out of experience and in ignorance of the raws of heredity. Forlowing
Leeuwenhoek's discovery of microorganisms and after a first glimpse was
gained in the mid-I9th century of the metabolism of microorganisms, specific
Processes were devised for producing prlmary products and biomass by means
of microorganisms, e.g. laetie acld, butanol, acetone, ethyl alcohol,
citric acid, glycerin, nutritive and feeding yeasts. l,Iendel,s discovery of
the laws of heredity in 1855 permitted controlled breeding within the natural
Iaws, which prevent transfers of genes between unlike species. The production
of penicillin in the forties ushered in a new era. To make large quantities
it was necessary to cultivate the mould free of foreign germs. The develop-
ment of suitable processes for this purpose facilitated the production of
many other antibiotics, other metabolic products and the isolation of enzlzmes
on a large sca1e. The culture of improved varieties reached a further stage
of development with the deliberate induction of genetic mutation (mutagenesis).
This technique was used very successfully with microorganisms and in the last
few years great strides forward have been made. The individual building
blocks of the metabolic mechanisms, enz)rmes, can be isolated from the living
cerr, fixed on inanimate supports and in this way used in large-scare pro-
cesses. The technique of genetic engineering, deveroped in r973, permits
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the combinatj-on of different kinds of genes across the natural barriers.
This is the point of departure of the proposed research programme.
Basic principles of modern biotechnoloqv
The following is a very brief summary of the more important concepts
(underlined).
(a) CeIIs and molecules
4. Living organisms consist of ceIls. A living ceII is composed of different
inanimate molecules. The different classes of molecules have quite specific
functions within the ceIl. But a cell is more than the mere sum of its com-
ponents. Only the specific combination and arrangement of the molecules
bring about the functions which characterize living organisms such as
metabolism, the generation of energy and reproduction. Ir{olecules can also
perform their individual functions outside the combination that makes up the
living ceIl.
(b) Enzymes and bioreactors
5 - Most of the chemical reaetions occurring in metabolism take place extremely
slow1y at normal temperatures and pressures in the absence of agents (catalysts)
to speed up the reaction. In the living cetl special protein molecules, the
enzymes, increase reaction rates by a factor of IO,OOO miltion and more.
EnzYmes are the most effective catalysts known to us. They act selectively,
and in a mixture containing many possible reaetants accelerate precisely one
reaction. This property is most valuable in chemical processes.
EnzYmes also retain their catalytic properties outside the living cell.
They are isolated industrially from microorganisms (about 300 tonnes enzymefear
worldwide). An enzyme is unchanged by the chemical reaction which it catalyzes.
Thus in principle it can be used over and over again. Horrrever, reactions
take place in solution. Atthough it is theoreticatly possible to recover the
enzlrme from the sorution, it is difficult and much too costry. one way of
solving this problem is to bind the enzyme to a mechanical support such as
cellulose or aluminium oxide (immobitization). When the reaction is over,
the immobilized enzyme ean then simply be removed from the solution together
with the support. This method can be further refined if the reaction solution
is pumped continuously past imnobilized enzyrmes in a tank (bioreactor). The
use of bioreactors substantialty reduces the times required.
(c) Deoxyribonucleic acid (DNA) and protein svnthesis
6. A riving cerr is a protein factory. rt produces protein molecules
combining the components of proteins, i.e. the 20 different aminoacids
particular sequence. The blueprint is contained in the molecule which
the genetj-c information, deoxvribonucleic acid (DNA). DNA consists of
by
ina
carr ies
a
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backbone and four different DNA eomponents, called bases, representing the
genetic code. These are adenine (A), cytosine (c), guanine (G) and thymine
(T). The bases are arranged along the DNA chain. A sequence of three bases
in a row on the chain (base triplet) indicates a word in the Sg!eEg--9oq-9.
For example, the base triplet c-A-c stands for the aminoacid glutamate.
Each word of the code stands for a particular aminoacid. The arrangement
of the base triplets along the DNA ehain thus determines the composition of
a protein molecule. The genetic information contained in the DNA molecule
is therefore translated in the cell into the protein structure, which by
virtue of its quite specific form is able to perform its function, e.9. of
an enzlme.
Because of its strategic importance for the ceII, the genetic information
is stored in a special way, in duplicate. However, two separate chains of a
DNA double chain are not identical but complementary. Their relationship is
one of lock and key.
The part of a DNA chain which encodes the composition of a prctd.n is oalled
the Sjruc!_ura_I__gS_qe. In addition to the structural geoes, DNA also cairies oPera-
tionat orders, refufalq___gFrEs which ae also expressed in cede by means of bases.
T'he simplest of t.hese Orders are 'start' and 'stop'. But there are also mOrc
complex orders. Ttrey are necessary because the DNA of each eell contains aII
the information which may ever be needcd. But only parts are needed at any
cne time. The regulator genes corfiol which part cf the information is read off
when anC 'g!.ressid' , i.e. translated into proteins-
The genetic code is universal. It is found in the ceIls of bacteria,
algae, plants, animals and man. Thus a piece of foreign DNA introduced into
a bacterium is reproduced by its metabolic mechanism when the bacterium
reproduces by ceII division. However, the regutator genes of Heria are dif ferert
from those of higher cells. For this reason animal DNA is not automatically
expressed in bacteria. But there are processes by which these expression
barriers can be overcome.
(d) Genetic manipulation and DNA recombination
7. Genetic manipulation means deliberate interference with genetic informa-
tion, i.e. with the chemical composition of the DNA. Until a few years ago
it was only possible hasically to change the bases of a chain present in
nature (mutation). For some time now, it has been possible to incorporate
genes of one type of cell into the DNA of another type. The new genes are
reproduced together with the host cells as part of their genetic information.
Under certain conditions the foreign DNA may also be expressed, i.e. trans-
lated into proteins, in which case the host celI acquires new characteristics.
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Cleavage site DNA ehain (e.9. mouse)
Plasmid(r) \'/(et
I
Split into fragrnents by enzlrmes
I
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6
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t---
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Fiqure 1: The process of gene transplantation (after
Stanl.ey N. Cohen, 'The Manipulation of Genes',Scientific American, July 1975, p.30.)
into bacteria
-L2- PE 65.864/f:-o.
(4) /,-\\
.4rrnrfer of vector
TTAA
.4X^
There are various methods for transferring genes to other cells. The
method most frequently used for transfer into bacteria is briefly deseribed
below by way of introduction to genetic engineering anci to the main principles
of the technique. (See Fig. 1).
Phase 1:
8. The essential part of the genetic information in a bacterium is located
in a large ring-shaPed DNA molecule, the bacterial chromosome. Bacteria may
also contain small DNA rings called plasmids. Thql carry special information
such as resistance to antibiotics. Plasmids can be separated from the other
cel1 components and isolated.
Phase 2:
9. Special restrictirao enzvmes (of which there is a variety) cleaveDNA mole-
cures at specific sltes. The enzyme reeognlges these creavage sites gy
specific base comblnatLons. In the example illustrated, a cut is made after
the base sequence TTAA (thymine-thymine-adenine-adenine). A plasmicl generally
contains only one cleavage slte.
Restriction enzymes can be used not only to cleaveplasmids of host cells.
There are also cleavage sites along the chromosome of the cell from which
genes are to be transferred. By skilful use of restrictlon enzymes individual
genes can be cut out of the chromosome.
Phase 3:
10. The piece of DNA from the donor cell can be inserted into the segrnented
bacterial plasmid. Then the plasmid ring can be closed again in a further
step. A plasmid which has been manipulated in this way is called a vector.
Phase 4:
11. The manipulated plasmid (vector) now containing the foreign DNA as
an integral component can be infiltrated into the bacteria like a 'Trojan
horse'. The whole Process is referred to as 'cloning' the foreign gene into
bacterium celI. The plasmids are then reproduced with the bacterium and
with them the foreign DNA. A colony of bacteria all containing the same
fragrments of foreign DNA is ca1led a clone.
Application of molecular bioloqv
L2. In any discussion of the possible applications of molecular biology, a
distinction has to be drawn between enzyme engineering and genetic engineer-
ing. Enzymes are already being used in industrial applications and their
usefulness is therefore easier to define, whereas in the case of genetic
engineering it is at present only possible to indicate potential areas of
application.
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(a)
13.
Use of bioreaccors.
This technology makes poseible:
chemical processes at Iow temperatures perm5-tting energy savings,
cheaper manufacture of products which can be obtained only with
difficulty by conventional chemical processes,
the use of bioreactors for controlled waste-water purification,
the medical application of small bioreactors as replacement organs
(e.9. compact artificial kidneys) or for treating congenital enzyme
defects (e.9. phenyl ketonuria).
The advantage of bioreactors over conventional processes with enz]rmes
is clearly shown by the following example.
100
chequered column: staff costs and
ener9y
 B
Source: Kula, R.!1., Chemie in unserer zeit 14 (1980) 61
(b) Possible uses of qenetic enqineerinq
14. For the moment the value of genetic engineering has only been demonstrated
in the field of basic research. Important new results have been produced con-
cerning hitherto unknown principles underlyi-ng the organization of genes and
in particular those of higher organisms.
15. As far as application is concerned, however, the technology is still in
its infancy. The following list therefore gives a few of the possible areas
of application, although long periods of research may be required before they
reach the stage of industrial application:
Iarge-scale production of hormones,
production of interferon (a substance for combating virus diseases and
perhaps also cancer),
Fiq.2
A = conventional
B = bioreaetors
vertieal axis
black column
white column
: Comparison of costs
of production of
L-amino aeids
Process
: relative costs in %
: raw materials costs
: costs of the enzyme
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- 
production of vaccines against infectious jaundice,
- 
production of vaccines against animal dysentery (up to I0% of new-born
calves and piglets in the USA die from this disease),
- 
production of vaccines against contagious diseases without using infec-
tious germs (greater safety in production),
- improvement of microorganisms used in the production of enzymes, anti-
biotics, etc.,
- 
replacement of energy-intensive nitrogen artifical fertilizers by an
expansion of biotogical nitrogen fixation,
- 
production of vegetable proteins having the amino acid composition of
animal protein (which may lead to a reduction of the energy input for
essential proteins in human food to less than sne tenth of the present
figmre),
- 
production of improved useful plants by somatic ceII hybridization,
- replacement of chemical high-pressure and high-temperature processes
into biochemical processes operating on a low energy input,
- biological processing of chemical by-produets without fresh production
of polluting waste (e.9. production from methanol of bacterial biomass
which can be used for animal feed),
- biological conversion of solar energy.
16. Most of the extremely interesting areas of application mentioned here
will however require considerable lead times. It is not possible to predict
with any accuracy whether the practical difficulties will be solved satis-
factorily. Some of them are already known:
- many genes from other organisms are not stable in the host bacterium
used and therefore are destroyed when the baeterium reproduces;
- as in the immune system in higher organisms, there are also mechanisms
in bacteria capable of distinguishing between their own and foreign
proteins and which lead to the desired foreign protein being destroyed;
- a similar problem can occur with the overproduction of a substance
which on its own is stable. One of the new possibilities of genetic
engineering is to design high-efficiency strains of organisms for
specific products. Where a bacterium produces large quantities of a
substance it may happen that this substance is then decomposed. Thus
in such a case there is a quantitative limitation.
Risks in qenetic enqineerinq
17. Shortly after the discovery of the technique of DNA recombination,
American scientists pointed out the possible risks and dangers.
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This topic was the subject of a report by Ivlr CERAVOLO (PE 64.494) on
the proposal for a directive establishing safety measures against the con-
jectural risks associated with recombinant DNA work (Ooc. 55/79\ - Your
rapporteur wiII therefore confine himself to those aspects which are of
direct relevance to the research programme.
Safety quidelines
18. Following the discussion referred to above, safety guidelines were issued
in aII industrialized countries classifying possible experirnents. The inid-
vidual classes are then made subject to physical and biological safety
measures.
19. The physical measures have been adopted from previous experience in work
with infectious germs. They range from working with gloves and automatic
pipettes through the destruction of experimental material by heat (autoclaves)
to completely sealing off the laboratory from the outside. The different
Ievels of physical precautions are referred to as LI to L4 (also PI to P4).
20. Biological safety measures include the trse of crippled bacteria as host
organisms which cannot multiply outside the laboratory or can only do so
with difficulty. The different IeveIs of biological protection are referred
to as BI and 82 (also EK1 and EK2). Although these measures can never com-
pletely exclude risk, they do help to reduce it substantially.
2L. It is particul
of the guidelines
arly relevant to the proposed programme
varies from one llember State to another.
that the strictness
The following
summary shows this clearly.
Summary: Safety provisions in the various countries(by John TOOZE with the addition of the revised Germany guidelines)
DNA - sourcefor a
' shotgun'
exPeriment
USA
( new)
France Germany
(new)
Germany(old )
Nether-
Iand s
United
Kingdom
Primate(ape, man)
MammaI
fnvertebrate
P4
P3
P3
P2
P2
P1
EKL
E1<2
EK[
E1<2
EKL
EK2
P3
P2
P3
P2
P2
PI
EKl
Et<2
EK1
EK2
EKT
EK2
P3
P2
P3
P2
P2
P1
EKl
EK2
EKL
EK2
EKI
EK2
P4 EK1
P3 EK2
P4 EKL
P3 EK2
P2 EKL
P4 E1<2
P3 EK2
P2 EKL
P4
P3
P4
P3
P2
P1
EKl
EK2
EK].
EK.2
EKl
EK2
'shotgun' experiment = cloning of aII of one cell's segmented DNA.
I = lowest safety level, 4 = highest safety level; P = physical safety,
EK = biological safety
Source: H. Schultze: Nutzen und Risiken der Gentechnologie, 1979.
22. fn practice the varying guidelines amount to a distortion of competition.
In Europe Lhere are no more than a few P4-IeveI laboratories. The cost of
- 
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a P3 laboratory is about 100,000
is Iower in the case of a safety
level EK2 take longer because of
bacteria strain.
EUA. The number of staff per place of work
laboratory. In addition, experiments at
the slower reproduction of the erippled
23. with the exception of the United Kingdom, the safety guidelines are not
Iegal1y enforceabl-e. Compliance is either voluntary or more often ensured by
making the provision of research funds conditional on the observance of the
guidelines.
Three consequences flow from this:
- the harmonization of the guidelines must be taken further, this is what
the cornmission is aiming to achieve with its proposar for a councir
directive (cOtttt(781 644 final);
since with the exception of the United Kingdom there are no IegaIIy
binding regulations, research contracts should stipulate that the pro-
vision of funds shall be conditional upon complianee with the national
safety guidelines;
in the event of excessive disparities between national safety guidelines
for a specific project, the Commission should link the provision of
funds to the strictest regulations.
Risk assessment
24. The risk in using certain technologies, e.g. nuelear energy, is ascer-
tained by estimating the probability of harmful events. The events themselves
are already known as are the possible consequences. But in genetic engineer-
ing the risks are con'iectural because no harmful event has yet occurred. For
this reason, possible incidents are postulated in the form of scenarios.
Most of the scenarios are concerned with new synthetic germs and with the
disturbance of the already endangered biotogical balance. Unlike industrial
installations, the possible danger from sythetically produced living organ-
isms is not merely local. Ornce released into the environment, microorganisms
multiply and spread independently. They can never be recovered. For that
reason special care is called for.
25. Current risk assessment and the associated safety measures relate to the
scale of laboratory experiments. Thus there is a quantitative limit of 10
Iitres on almost all experiments involving bacterial cultures. But many
problems only become evident when the experiment is scaled up to larger
volumes e.g. 50 or 100 litres and later, in production, I,OOO litres. At
that point, in the present state of the art, it is no longer economically
feasible to ensure that microorganisms are securely contained.
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26. Risk assessment is also difficult because there are still some gaps in
our scientific knowledge. It is true that in the last few years, particu-
Iarly in the USA and EMBO, experiments have been carried out in an effort
to clear up unanswered questions. But some of the answers remain elusive.
In addition, successful risk assessment requires the continuous collection,
coordination and evaluation of the data acquired. Therefore in September
1979 the US National Institute of Health (NIH) submitted a programme for
further research into the problem of safety. The Commission for its part
produced a study by SARGEAI{I and EVANS on 'Hazards involved in the indus-
trial use of microorganisms' (EuR 6349, 1979). But the study did not
consider the problems of genetic engineering. The European community should
take prompt steps to promote the examination of questions of safety in its
territory because if it does not do so they may prove to be a barrier to
the industrial application of this technology.
Ethical problems
27. The proposed research programme evisages the genetic manipulation of
microorganisms and plants. The knowledge thereby obtained could however
Iead to this technology being applied to human beings. At that point, if
not before, ont only scientific and economic but also ethical problems wiII
be raised. These questions are already being discussed by philosophers and
in religious circles. In a speech to IJNESCO in Paris on 2 June 1980, Pope
John-Paul II said:
'Whereas the role of science is to serve mankind, it is all too often used
for purposes which destroy the true dignity of man and human life. This is
the case when scientific research sets itself aims or when its results are
put in the service of aims which run counter to the welfare of mankind.
This is true in the case of genetic engineering, biological experiments and
the development of chemical, bacteriological and nuclear weapons' (quotation
from: L'OSSERVATORE ROMANO, cerman weekly edition, 6 June 1980).
2A. Parliament cannot evade the question of interference with human genetics.
There must be some discussion on this subject before it becomes a praetical
possibility. The widespread view that in general pure scientific research
precedes a second more praetical phase of applied research, is not supported
by the facts of the history of science and technology. Thus it can be shown
that after the discovery of nuclear fission (i.e. at the basic research stage)
the development of the atomic bomb was politicallv virtually inevitable. It
follows that the social and political consequences and the ethical implica-
tions of recombinant DNA should be discussed at the basic research stage, and
that means now.
-18- PE 65.964 /ftn.
II The need for, possible uses and Iimitations of a corununitv research
proqramme
29. As the Committee on Budgets, asked for its opinion, has rightly remarked,
in terms of volume the proposed biomolecular engineering research programme
falls into the category of large-scale progralnmes and is only exceeded in
size by the JET programme, the energy research Programmes and the radiation
protection programme. For this reason aIone, a strict examination of the
need for the programme is called for.
Current European research
30. Research into biomolecular engineering is already being undertaken in
Europe. It is therefore necessary to consider whether the Community's
research programne overlaps with existing research progranmes.
31. This is denied in a study on genetic engineering in applied biology
(EUR 6078, 1978) carried out for the commission. The author, Professor
A. R6rsch (also Secretary-GeneraI of the EuroPean llolecular Biology Confer-
ence), stresses however that this is his personal and private opinion'
Therefore careful attention has been given to examining this assertion'
your rapporteur was unable to find anv element of competition between the
Commission,s proposal and existinq European efforts provided the Communitv
confines itself to promotinq applied research'
European Molecular Bioloqv orqanization (EMBo)
32. EI,IBO was set up in 1963 by scientists in Geneva as a non-profit-making
organization under Article 60 of the swiss civil code. It was intended to
advance the development of biomolecular research in Europe by exchange
fellowships, refresher courses, the setting up of a EuloPean Laboratory for
Molecular Biology and a programme for the promotion of research' To date'
the first three aims have been achieved. In 1978 the organization included
researchers from 18 countries, mainly from EuroPe but also from Israel (18) '
Australia (1) and the usA (4). Of 348 members in January L978, 248 came
from I countries of the Community (none from Luxembourg). Since L97O'
following a period of financing by the Volkswagen Foundation, the finances
of the EMBC have been administered by EMBO'
European MolecuIar Bioloqv Conference (EIvlBC)
33. In 1970, 13 governments (Austria, Denmark, Federal Republic of Germany,
France, Greece, Israel, Italy, Netherlands, Norway, Spain' Sweden'
switzerland and the united Kingdom; the Belgian Fonds National de Ia
Recherche Scientifique is associated) signed an agreement setting up the
European lvlolecular Biology Conference. This organization was intended to
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ensure the tong-term financing of EMBO
laboratory. Since then other countries
(1976) and lcei.and (1977 ) - The 1978
anci remains at the same level for 1980.
include inter alia:
(a) the award of
exchanges of
(b) 20 workshoPs,
fellowships and the planned European
have joined: Ireland (I975), Finland
budget was DM 5,850,328 (2,333,9I4 EUA)
The EI"IBC's plans for the eighties
230 short-term and 155 long-term fellowships annually for
scientists;
14 practical and 5 theoretical courses Per annum;
(c) the award of 10 lectureships per annum;
(d) an annual EMBO symPosium-
34. An analysis of the research topics of the recipients of exchange
fellowships in 1979 showed that out of 243 short-term fellowships, 65 (i'e'
27%) related to genetic research. The working tiEIes of projects, however,
do not permit precise categorization so that the number may be even higher.
European ltolecular Bioloqv Laboratorv (EI'IBL)
35. In 1973, at the instigation of the EI'IBC, l0 countries (Denmark, Germany,
France, IsraeI, ItaIy, Netherlands, Austria, St/'eden,Switzerland, United
Kingdom) decided to build and run their own European laboratorv in Heidelberg
(Federal Renrrhl-i-e of Germanrr) . si-nep 5 llav I978 the lahor'atnrr" o hr1!:1:' lualif ied
staff has worked under the direction of Sir John Kendrew on basic research
into molecular biology. The 1979 budget was DI'l 3I, 344, OOO (12,504,290 EUA) '
At present 40 researchers work in the laboratory. In accordance with Article
II of its statutes it serves n-g--commg-Egial -purpose. There is a special
ciepartment for research into recombinant DNA. At the end of 1978 four
research grouPs were working in this field - now there are seven' Since
recently the EMBL has offered scientists one of the few P4 top-Ievel safety
laboratories in EuroPe.
States of the Communitv
36. A Community project is only relevant when it does not compete with the
existing efforts of the tr{ember States. Another factor in the assessment of
the need for a Community prograrnme is the differing state of development of
research and technologY.
3i . Despite the Commission's enquiries and efforts it was unable to obtain
fuII information for a precise assessment. The best that can be done there-
fore is to try to clarify the research situation in the light of selected
information.
ituation
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38. International exchanges of researchers provide a good yardstick for
research activities. Visiting researchers always seek out the more attrac-
tive laboratories. conclusions may be drawn from their country of origin
as to the countries in which the science is already weII developed or still
in its infancy. EMBO's short-term fellowships to Community countries were
therefore analysed with regard to scientists' host countries and eountries
of origin (Luxembourg is not included as it is not a member of the EMBC).
Figure 3 shows that research is most highly developed in the United Kingdom,
the Federal Republic of Germany and France. Italy sends far more researchers
than it receives 
- a clear indication that in Italy research is still in the
development stage but very active.
Fiqure 3: Exchanges of scientists among the countries of the Corununity inthe field of molecular biology (number of recipients of El,:gg
fel-Iorvships in 1979 bv host country and count-ry of origin)
verticql axis
horizontal axis
f ert-hagq__S_g]umg
riqht-hand column
: number of exchange fell-owships
: I"lember States in the following orcjer: Belgium, Denmark,
Germany, France, Ireland, ItaIy, Netherlands, United
Kingdom
: number of felLowships to a
: number of fellowships from
origin )
l,tember State (host country)
a Member State (country of
Source: European lt{ol-ecular Biolog'y Conference, Annual Report fox L979
L7.3.1980, evaluation of part II.
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39. In relation to research into recombinant DNA no representative figures
were available on research expenditure, publications, number of laboratories
or research groups. The survey of laboratories concerned with genetic engin-
eering on plant cells covers only a single field, albeit an important one for
the Community.
Table 1: Genetic engineering on prant celrs in the Member states(number of laboratories and research groups)
Itlember State Laboratories Research Groups
Belgium
Denmark
Germany
France
Ireland
ItaIy
Luxembourg
Netherland s
United Kingdom
10
3
t8
l3
6
I
0
6
9
15
I
24
36
9
20
0
I4
26
Source: Analysis of a list of addresses supptied by the Commission (1979
situation)
The table gives the impression that development in this specialized fietd
has reflected the general development of molecular biology in the llember
States.
40. The best illustration is given by the field of enzlzme immobilization.
The study by THOMAS for the Commission on 'Production of biological catalysts,
stablization and exploitation' (EUR 6079, 1978) also contains data on labora-
tories and companies although more in a descriptive than precisely comparative
form. It is also unclear whether the information is complete - for example
the author does not mention himself or his laboratory. The following table
has been compiled in conjunction with an evaluation of a study of patents
carried out for Directorate-General XIII of the Commission.
-22- PE 65.86q/fin.
Table 2: The situation in the Member States in the field of enzlrme
immobilization
Itlember State Companies Universities Inventionspatented
(1970-1978 )
Belgium
Denmark
Germany
France
Ireland
ItaIy
ILuxembourg-
Netherland s
United Kingdom
1
I
4
5
1
4
2
1
II
7
I
4
2
1s
2
18
15
2
1
I
5
I3
TotaI 16 43 58
Sources3 Evaluation by: D. Thomas, 'Production of biological catalysts,
stabilization and exptoitation' EUR 6079, 1978;
J. Sigmond, patent report ,Immobilization of enzymes" 1979.
Companies: Number of comPanies concerned with the application of or
research into enzyme immobilization'
Universities: Number of basic research grouPs.
Patents: Number of patents applied for by companies or individuals.
'lr This is a patent application by a Luxembourg national on behalf of a US
company.
As far as industrial use is concerned, cermany, France and the United
Kingdom have a clear lead over the other l'lember States'
4L. The promotion of applied research in the field of biotechnology varies
considerabty from Member State to lrlember State. Information was available
for Germany, France, the United Kingdom and lta1y'
Federal RePublic of Germanv
42. The Ministry for Research has run a biotechnology Progratnme since 1972-
For the period I979-1983 the 'Leistungsplan 04-Biotechnologie' provides for
DM 313 miltion (125 million EUA) to be spent on projects. This does not
include the activities of the big state research institutions. DM 5'7 -4
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mirlion (23 mirrion EUA) are earmarked for bioreactors arone. That
corresPonds to the amount which the Community plans to spend on its entire
research Programme. In 1979 altogether DM 15 million (6 mitlion EUA) were
spent on genetic research in the Federal Republic of Germany. These figures
reflect the great importance which Germany attaches to biotechnology.
France
43. In France there is a biomass prograrnme coordinated by the Commissariat
i I'Energie Solaire on which 3.28 mitlion EUA were spent in 1979. There is
no special biotechnology Progralnme. The report on 'sciences de Ia vie et
soci6t6' (Paris L9791 to the President.of the Republic contains a number of
recommendations for research projects including projects for the development
of bioreactors and for nitrogen fixation. Expenditure on biotechnology is
currently estimated at FF 20 million (3.4 million EUA).
Unit.ed Kinqdom
44. It is difficult to quantify how much is spent on research as there are
no official statistics. The report 'Biotechnology - Report of a Joint Working
Party' (Ivlarch 1980) estimates government support at 
€5 million (8.2 mitlion
EUA) per annum. The report by Mr SPfNKS contains practical proposals with
costs estimated at f,10 million per annum.
Italy
45. The National Research Council's (CNR) 24 applied researeh programmes
include 6 on biotechnology:
blomedical technology
breeding
virus research
research into r
genetic s
irnprovement of
No figures are available because of the Italian government's failure to
provide information.
Need for a programme
46- The Corunission justifies the need for a programme by referring to the
lead of the USA and ilapan on the world market. In support of this argument
it produces figures on patents. Since the importance of patents lies not in
their number but in their quality, such information has only limited value.
new protein sources
plants by genetic manipulation.
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47. Thus a number of Japanese patents relate to the produetion of glutamate
and soy sauce ingredients. Your rapporteur is very fond of Asiatic cuisine
but cannot see the relevance of these patents to the world market. The other
data found after further research point more persuasively to the Iead of
Japan and the United States. This view is also expressed in the British,
French and German studies on the importance of biotechnology. But in each
case these are merely opinions rather than precise analyses.
48. The need for a Community prograrune can only be shown conclusively by a
clear analysis of the economic and social demand and the consequences of the
new technology. This must include comparable information from different
countries on, for example:
the number, size, turnover and earnings of companies in the field,
companies' shares of the world market for specific products,
the proportion of cDP in the different countries attributable to
biotechnology,
the importance of biotechnology for employment,
the promotion of research in the individual countries,
a conclusive analysis of the patent situation,
an appraisal of the market for new products,
the relationship of research costs to economic value,
a determination of social demand,
an estimate of the research costs for that demand,
an analysis of the overall social consequences of introducing the
technology (e.9. effects on employment).
There is no sign of any such information. The two studies on which the
proposal was based, fy niinscH and THOMAS, were carried out by molecular
biologists- They are known to be very competent in their field. They cannot
however be expected to do the work of economists. thus nijRSCH's study con-
tains no relevant information at aI1. THOMAS describes the enzyme technology
situation in different countries qualitatively and not in such a way as to
afford comparison.
49. The Commission's explanatory memorandum does not therefore disclose any
pressing need for the programme from the point of view of foreign trade consid-
erations. But the arguments put forward by the Commission and others cannot
be dismissed out of hand.
50. The Commission puts further weighty arguments for a Community
have nothing to do with EuroPe's competitive position on the world
(a) There are no trade barriers between the Member States of the
but they are at varying stages of economic arowth which must
ized by Community efforts. Community actions in relation to
technologies can contribute to achieving this.
' action which
market:
Community,
be harmon-
important
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(b) the harmonization of safety guidelines for work with recombinant DNA
is important if only on account of possible distortions of competition
within Europe. A Community research programme can help to achieve
this if the provision of funds is Iinked to compliance with uniform
guidelines.
(c) There are less profitable areas which cannot be covered by industry,
such as the very limited market for medical bioreactors whi.ch will
require support from public funds. In such cases joint efforts by
the Member States will save time and money.
For these reasons a Community action will in any event be useful, and so
it should not be held up for want of a precise economic analysis. The social
consequences of biotechnology are in any event the subject of the programme
on'Forecasting and Assessment in the fierd of Science and Technorogy'
(Doc. xII/93/8o) the first results of which should be available in 1982.
For the evaluation of the research programme on biomolecular engineering
in the meantime Parliament should therefore demand a study on the economic
and social demand and their consequences. Approval of further funds from
the budget will then depend on the results of this examination.
Form of Communitv action
51. Three forms of action have been developed for the Community's research
policy:
direct (Joint Research Centre)
coordinated (coordination of national actions)
indirect (award of research contracti Uy the Community)
It must now be considered which of these possibilities best suits a
prograrnme in the field of biomolecular engineering.
Direct action
52. Biotechnology does not feature in the multiannual programme of the Joint
Research centre 1980-1983 (cot't(zg) 121 finat). on a visit to rspra your
raPporteur discovered that biological research is in fact carried out there,
but it is essentially environmental research carried out under the auspices
of DG xrI. Two Ispra scientists are included on an address list of researchers
concerned with genetic engineering on plant celIs. It is significant that at
the moment there is neither a safety laboratory nor the other necessary equip-
ment for this type of research. At present it is not possible to carrv out
a biomolecular enqineerinq research proqramme of the scope envisaqed at thegei@.
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53. The Commission should however consider whether a research group could
.be put together at Ispra to take part in the programme. In fact most Member
States lack institutes conducting research in the area between basic and
applied research.
54. The setting up of such a group would be valuable also having regard to
the need for safety measures in work with recombinant DNA. In drawing up
such guidelines governments are advised by scientists whose wish it is to
carry out their research as far as possible without interference and who
are to some extent involved with industry through consultancy contracts or
shareholdings. It would definitely be desirable to have experts not subject
to these constraints.
Coordinated action
55. A coordinated action would in principle be possible. With this type
of action the influence of the Commission, which is desirable for various
reasons, would not be very strong.
Indirect action
56. The indirect action proposed by the Commission is the best way to carry
out this research programme.
III. Difficulties in realizinq the aim of the proqramme
57. The stated aim of the programme is to suPPort EuroPean industry and
agriculture. This formula is a thread running through the whole proposal
and clearly forms part of the Corunission's sales talk for this programme,
but critical examination reveals flaws in the argument.
The concept of a European industrv
58. Many large chemical and pharmaceutical companies in Europe are engaged
in research and development in genetic engineering. The major companies in
the Federal Republic of cermany are Boehringer of Itlannheim, Hoechst of
Frankfurt am Main, Schering of Berlin, and recently also BASF, while other
pharmaceutical manufacturers are also active in this fie1d. In the United
Kingdom, ICI is involved in developments in genetic engineering while in
France and ftaly there are well known companies also oPerating in this field.
Clearly the Commission has these companies in mind when it speaks of the
European industry.
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5g.Howevertheactualdevelopmentoftheapplicationofgeneticengineer-
ingdoesnottakeplaceintheconventionallargecompany.IntheUSAsn..all
individualundertakingshavebeensetupsuchastheCetusCorPorationof
Berkeley,CaliforniaandGenentechlnc.ofSanFransisco,Ca}ifornia.By
virtueoftheirflexibi}itythesetwocort::anieshavesucceededinrecr'uiting
alargeproportionofthecompetentscientistsinthisfieldeitherdirectly
asemployeesorasconsultants.Theintellectualcapitalofthesecompanies
is varued so highly that a number of rarge companies 
such as Eri Lirry' in
the case of Genentech Inc" and Standard Oil of Indiana' 
in the case of the
CetusCorporation,havegainedaccesstotheirexpertisethroughcontracts
orcapitalinvestments.Noneofthesenew}yfoundedcompanieshasany
ambitiononedaytoprodtrcepharmaceuticalsthemselvesonalargescaleor
tobuildupthenecessarysalesnetwork.Tlreyprefertoselltheirexper-
tisetothegiantsofindustryratherthancompetewiththem.Thisform
oforganizationwillthereforerrakeitpossibleinthefuturetoretain
thepresentflexibitityalrdtheassociatec]highlevelofinventiveoutput.
60. A company named 'Biogen' has been set up in 
Luxembourg and Geneva
withthesameideasinmind.Thisisaninternationalcommercialcompany
consistingofscientistsaboutwhomverylittleisknown.BiogenS.A.of
Geneva was registered in Luxembourg in 5 May 1978. 
The firm was set up
withventurecapitalfromlnternatiorralNickel(INCo),aCanadianmining
comPany.ItsshareholdersarecorBpaniesoneithersideoftheAt}antic(1\.
6l.TheobjectofBiogenistodeve}opcommercialproductsinthephalm-
aceutical, chemical and energy fields using modern 
microbiological methods
andinparticulargeneticengineering.Biogen,sscientificconsultants
includeeightscientistsfromtheUSAandvariousEuropeancountries:
ProfessorW.Gilbert,chairman,Harva):(]University(USA);Professor
B.Hartley,ImperialCollegeofscience&Technology(London,England);
ProfessorP.H.Hofschneider,Max-Planck-Institut(Munich,Germany);
Professor B. Mach, University of Geneva (Switzerland); Professor 
K. l,lurray,
UniversityofEdinburgh(Scotland);ProfessorH.Schaller,Universityof
Heidelberg(Germany);ProfessorP'Sharp'Ir{assachusettslnstituteof
Technotogy(USA);ProfessorC.I0eissrnann,InstituteofMolecularBiology(zurich, Switzerland)'
62.InrelationtoBiogen,itshouldbenotedthatthereisamissinglink
inthedevelopmentofgeneticengirreeringforindustrialProcesses.Basic
researchinstitutionsareinterestedi'nlookingattheprincipleofgenetic
expressioninordertoshowthecircumstancesunderwhichgeneticexpression
ofthestructuralproteinsofthehepatitis-B-viruscanbeobtained.But
itisnotintheinterestofsuchinstitutions,norisittheirPurpose,
oncetheyhaveestablishedtheprinciple,Eodevelophigh-outputstrains
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for use in industrial production. Converselv, manv of the larqe established
pharmaceutical companies, particularlv in Europe, are interested onlv in buv-
inq hiqh-output strains. There is therefore a development gap between the
basic research institutes and the established pharmaceutical companies. This
gap is now filled in Europe by Biogen.
Three things follow from this:
(a) SuPPort for Biogen means supporting US industry by virtue of the mixed
European,/American character of the companyi
(b) SuPPort for basic research has the disadvantages mentioned above and in
the following section;
(c) Support for research in the conventional chemical,/pharmaceutical industry
may entail financing 'finger-exercises' for scientists in industry who
have been recruited now in preparation for the day when high-output
strains and expertise will be bought. The pharmaceutical industry says
this quite openly: 'Virtually all the large pharmaceutical companies in
the Federal Republic of cermany have decided to devote attert ion to this
technology. They are in the process of setting up working parties to
collect know-how and to design projectp with the established groups to
some extent as insiders (who will in the meantime familiarize themselves
with the special problems of industry) In order to bdcome reason-
ably active in this field it is necessary 
- I hope that the scientists
agree with me - to engage at least two and I would say more realistically
four or five scientists to practise their finger-exercises on such pro-
jects'. (Professor Dr. w. Frommer, Federal Assoeiation of the Pharma-
ceutical Industry, Minutes of the BIitFT hearing, Bonn, 19-21 September I979)
Scientists and patents
53. Basic researchers and industry have different goals. The reputation
and career of an academic scientist are dependent on the publication of his
work in the scientific literature. It is therefore important for him to be
the first in the field. This aim is not always consistent with the aim of
securing a patent because the additional work necessary to obtain a patent
can take a long time. A claim witl not be allowed where its subject matter
has already been disclosed in a prior publication. Without patent protection
the knowledge obtained is accessible not just to the European industry but
to anyone.
Problems of patentinq microorqanisms
64. Patenting microorganisms presents a special problem in biotechnologry.
According to the European Patent Convention of 7 October 1977 and the patent
law of most of the countries signatory to the Convention, it is possible to
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patent new microorganisms not occurring in nature. This however requires
a sample of the microorganism to be deposited with a recognized institution.
The Convention provides that the culture must be available to third parties
on the publication of the European patent application. Account was taken
of the interests of the person depositing the microorganism in that anyone
who wishes to obtain such a culture must give the applicant or proprietor
of the patent an undertaking not to make t,he culture ivailable to other
persons and, where appropriate, only to use the culture for experimental
purposes until the European patent has been granted.
65. In some ways this protection is not sufficient for the industry. As
a consequence no applications for patents are filed and microorganisms are
kept strictly secret. How far the ratification of the Budapest treaty of
28 April L977 on the international recognition of the deposit of micro-
organisms can remedy the situation still remains to be seen. But in any
event secrecy is incompatible with the objects of the programme.
Effects of American patent applications on proiects 3, 4 and 5
66. On 6 November 1978 GENENIECH INc. filed three patent applications with
the European Patent Office in Munich. They cover the field of projects 3,
4 and 5 with a verv wide claim. The view of specialist patent attorneys
is that the patents will be granted. This could mean that inventions made
in connection with projects 3, 4 and 5 might be patentable but that the
patents granted would be dependent on master patents.
The underlyinq reason for the lack of development of biotechnolocnr in
Europe
67. In the explanatory statement to its proposal the Commission states
that the level of development of biotechnology in Europe is behind that
in the USA and Japan. It does not however state the reasons. In particular
it does not explain why European industry has hitherto shovrn so little
interest. The lack of applied research is only the slzmptom and not the
cause. One conclusion can be deduced from this: from the point of view
of. private industry, there was hitherto no market for this technoloqv in
Europe l
The question is whether this has changed to the extent that a Community
research programme could promote industrial developmcnt and, if so, why'.
The guestion is very important for the aim of the programme. Unless there
is strong demand, private enterprise will not take the results of basic
research forward to the stage where they are ready for application.
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68. It should be noted that the large-scale inCustrial application of
biotechnology in the USA and Japan was in response to dernand for cheap food.
The production of isoglucose from maize starch is an excellent e:<ample of
the application of bioreactors using j-runobilized enzyrnes. This is a way of
replacing sugar from conventj.onal sources (sugar cane, sugar beet). T,he
protectiouism of the Comrnunity's aqri,cultural policy has effectively pre-
vented the development in Europe of isoglucose production using biotechnology.
One company in the United Kingdom whicir was interesteo in this process has
since had to drop its plans.
IV. The plan for six research proiect-s
69. It is Ilot tlre tasft; oI Parlia.ment to judge tne quality t>!' the ;-.rrtrpgsir,rl
projects, but rather to concern itself with tlie ol:jectir,res of the arpplied
research. In this cctrnection the Commission's proposal. catls fo:r some
critical remarks (Annex f of Doc. ].-'i5Oi'791 .
The proposed programme is very ambitious. The proposed subjects enrbrace
everYthing which is conceivable at the moment,. Some of the suhjects are
still a long way from the application stage. The draft is less a prograrune
of specific objectives than a eollection of all possible research interests
designed to open up additional sources of finance. Close examination
reveals that the funds proposed witl be insuffieient for all the research
topics mentioned. It also remains uncLear how many research units will be
used on each project.
70. This being so, the Commission or the advisory corrunittee has a completely
free hand in setting the objectives of an applied researeh progl:amme.
Parliament must deeide whether it is willing to be fobbed off with rather
general aims such as supporting European inCustry, agriculture and enrriron-
mental pr*otectj-on. Your rapporteur recommends t.hat lh"_j:"rol3"ron_b1 asked
to tiqhten up_the proqramm anrl define clear goals. A reminder of Parlia-
ment's budgetary rights in relation to non-compulsory expenditure should
Iend the neeessary emphasis to this demand.
77. It is not the Eask of Pa::liament to submit a detailed proposal for a
tighter: Prografiune. But it should give the Commission some guidelines.
In view clf the Community's needs and the problems outlined in Sections
I(I7) and IIr, your rapporteur wouLd submit the following proposal:
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1. No projects should be chosen which have already been the subject of
intensive work in Japan and the USA. The }ead of those countries can
only be reduced in other as yet new fields.
2. The Commission shoulil choose practical projects aimed in particular
at:
- Iowering agricultural production costs (e.9. nitrogen fixation, souatic
ceII hybridization),
- Iowering energy consumption in the chemical industry,
- solving environmental problems,
- solving medical problems,
- using agricultural waste products,
- the biological exploitation of solar energy.
3. A number of experts consider that the research subjects proposed in
project 6 are covered by projects 3, 4 or 5. Everyone working in
this field must be concerned with genetic stability. Project 6 should
therefore be deleted.
4. In its place a new project should be included with a view to extend-
ing knowledge in the assessment of safety problems in research, and
in particular in relation to applied research.
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V. The Commission's proposal for implementinq the proqramme
72. The programme is to be implemented in the form of an indirect action
(I98I-1985) by means of cost-sharing contracts with private and state
organizations. There wiIl be a public invitation to tender. The maximum
participation from the Community will be 26 million EUA. The Ivlember States
are expected to provide 23.5 million EUA. The Commission is asking for six
posts (three A, one B and two C). In selecting prcjects and evaluating the
results, the Commission will be assisted by an advisory committee whose
composition is to be determined by the governments of the Mernlcer States.
The results of the programme will be made available to EuroPean industry
and property in inventions will pass to the contractor if he so wishes.
73. The Commission's proposals therefore contain nothing unusual. In spite,
or perhaps because of this, they call for some comment.
Orqanization of research work
74. The Cornmission proposes a research unit of three researchers, two
technicians, one Iaboratory assistant and secretarial assistance. Only the
most we1I endowed universities can afford a ratio of one researcher to one
technician. In industryr on€ researcher normally works with two or three
technicians. The Commission should therefore bring its proposal into Iine
with practice.
75. The Commission's proposal says nothing about money for materials
(chemicals, etc.). In biolmolecular engineering, operating costs can be as
high as staff costs. This is shown clearly by the example of the European
l{olecular Biology Laboratory.
Table : Structure of
Year
costs at EMBL, Heidelberg
Staff costs Running eosts
L977
r978
L979
DM 5,989,000
DI4 8, 529 , 000
DMl3,234,OOO
DM 4,625,000
DM 7,889,000
DM12,342,000
Source : European Molecular Biology Laboratory, AnnuaI Report 1978
76. The EMBL figures are confirmed by the structure of costs at five
German universities chosen at random. for special areas of biolmolecular
engineering as defined by the cerman Society for the Promotion of Research.
CIearIy, materials costs are a problem.
The Commission should therefore spell out in its invitation to tender
that it accepts responsibility for both staff and materials costs.
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Public invitation to tender
77. The Commission always publishes
Journal of the European Communities,
circulation. Scientists who have not
will certain not be among the readers
rapporteur even doubts whether anyone
Approximate
number of
research
units
invitations to tender in the OfficiaI
although this has only limited
previously worked for the Community
of the Official Journal (and your
reads it wiIIingIy) .
TotaI costs Ivlaximum Community
m EUA,/5 years Participation
m EUA'/5 Years
7A. The Commission should therefore ensure that the invitation to tender is
really public by advertising in newspapers and technical journals, not
merely to meet the formal requirement of a public invitation to tender but
in order to attract scientists who are not already in close contact with
the Commission or the national research agencies.
F inance
79. The total cost wiII be 47 million ELIA over five years. According to the
Commission's proposal, its participation in the programme for the period
I98I-I985 should not exceed 26 million EUA. The money is to be used for
the part-financing (generally 5el.) of the research projects and wiII cover
the eost of management, programme coordination and a limited numlcer of
posts for Commission staff.
Contract research 43
Manaqem€nt and
coordination
Expenditure on experts,
fees, meetings,
seminars, etc.
Commission staff(3A, 18, 2C)
47 23.5
0.7
r.8
26.O
80. The Commission assumed 57,000 EUA per researcher/year and a 6%
inflation rate for research costs. Apart from that, it does not disclose
how it arrived at its figures. Further calculation on the basis of three
researchers (composition of one research unit according to the Conunission
proposal) produces a figure for total costs of 41.5 mil-Iion EttA rather than
47 million EUA. The Commission should state what it intends to use the
difference for. (Note: explained by an inflation rate of 6.5% instead of 6%.)
81. 43 research units and 47 million EUA/5 years give an average cost per
research unit of 218,600 EUA/year. Your rapporteur has calculated the cost
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of one research unit on the basis of information on research spending
provided confidentially by the industry. Taking salaries at 1980 leveIs,
the result is 176,000 EUA/year for staff costs alone. If a 5% cost
inflation rate is included in the computation, the Commission's programme
will only cover staff costs. It has already been pointed out that the cost
of materials in biomolecular research is very high. Therefore if the
Commission is to remain within its financial limits, it must change either
the number of research units or, preferably, their composition (57,000 EUA
per employee per year in industry corresponds to a ratio of one researcher
to three techniciansl) .
Posts reouested bv the Commission
82. The Commission is reguesting three A posts, one B post and two c posts.
The Committee on Budgets has demanded careful scrutiny of this request'
83. Obviously the commission needs properly trained staff to carry out a
research programme, otherwise it cannot be expected to accept responsibility'
The Commission is asking not for permanent Posts but for temporary contracts'
The commission's proposal for the programme was prepared by the staff of the
biology and health protection (radiation protection) research Programme,
which in fact has other dutiest
84. It is however questionable whether three new A posts are needed' one
enzyme specialist and one genetic engineering specialist should suffice'
The one B and two c posts caII for no sPecial technical knowledge.
parliament should approve these requests for new posts only i-f the
commission can show conclusivel.y that the staff cannot be recruited from
existing staff.
Choice of pro-iects (advisorv committee)
85. For the purpose of selecting the research units and their integration
in research groups, the commission proPoses to set uP an advisory committee
for programme management. The advisory committee would consist of three
representatives per Member State appointed by their governments and three
representatives from the Commission. The committee's duties would be
adv5-sory in nature with the Commission retaining formal responsibility for
implementation. This arrangement corresponds to the practice introduced
between 1969 and 1975 by Council decisions. The terms of reference of the
advisory committee on research programme management were laid down in L977
(OJ No. c L92, 11.8.1977).
86. It is clear that the commission requires advice concerning the
implementation of such programmes. However, there are both political and
practical arguments against the Present advisory committee structure'
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(a) PoIiticaI reasons
87. In theorv the committee has only an advisory capacity' But in practice
it assumes the role of the council of uinisters despite the commission's
denial of this to parliament's Committee on Budgetary ControI. The present
programmeprovidesagoodexampleofthis.SincelgTTithasbeen
submitted to the scientific and Technical Research committee (CREST)
several times, in various forms, although CREST in theory has only advisory
status. This has resulted in considerable delay to the proPosal'
88. The role of advisory committees is being given careful consideration
in the committee on Budgetary control on the basis of a report by
Mr Marcel COLIA. The question is whether by this practice the Couneil is
in breach of Article 205 of the EEC Treaty, which provides that the
Commission shaII have sole responsibility for implementing the budget.
89" The committee's chairman, Itlr Heinrich AIGNER, has already indicated to
the Commission that Parliament attaches great importance to this point'
MrRYAN,theCommitteeonBudgetsco-raPporteuronthedraftprogrammehas
also expressed doubt about the role of the advisory committee.
(b) Practical reasons
go. This structure does not suit the programme. Every scientist consulted
(see annex) answered without hesitation that the programme would only con-
tribute to the rapidly expanding area of research into recombinant DNA if
the projects were selected by top scientists on the strictest criteria- And
the keynote should be quality rather than a fair share-out between tlember
States.
91. In practice, the governments of the Member States do not fill posts
on the advisory committees on research programme management according to
these criteria. A. lg77 survey on a number of such committees shows this
e l-ear ly :
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TabIe : Composition of advisorv committees (L977)
State
Government State
Represent.- reacarch
ative establiehment
Industry Uhivef,sity Status Total
unknown
Be Igium
Denmark
France
Germany
Ire land
Ita Iy
Luxembourg
Nether lands
united Kingdom
22
7
2L
5
2
4
l1
I3
20
L4
38
20
I3
29
I
27
30
5
L2
2
L4
6
5
2
4
I
I
)
2
2
55
32
56
65
27
54
5
55
53
7
2
6
2
I
9
I
I6
I
8
85
(2L%)
L92
(4e/")
5B
(L4%)
53
(t3%)
14 402(3%) ( rool")
Source : House of Lords, Select Committee on the European Communities
Research and Development in the EEC, Session 1977-1978, Sixth
Report, HMSO, London, L977
92. The clause which enables the Member States to appoint their experts
according to the criteria which they consider most appropriate has Ied to
a situation in which the committees are dominated by the representatives
of ministries and state research establishments.
93. The specialist officials of the national governments and scientists
in state research establishments are no doubt qualified for their specific
duties, but it is open to question whether many of them have an aclequate
scientific arasp of the areas which the programme covers. This is
particularly true of Ivlember States which do not yet have state programmes
for the promotion of biomolecular engineering. Obviously the level of
knowledge within national research agencies depends on their particular
field of activity.
94. In the case of efforts to promote research in the Member States (see
the study by the ESC on organization and management in Community research
and development, Doc. CES 91/80) there are very good reasons why the
various advisory committees are constituted differently. In the Federal
Republic of Germany, substantial funds are provided by the DFG (Deutsche
Forschungsgerneinschaft) which is an autonomous body under the direction of
scientists chosen by election of the members of the committees of the CNRS
(Centre National de Recherche Scienti.fique),an autonomous corPoration under
public Iaw in France, half are appointed and half elected by scientists.
Of the total of 140 members on the 11 advisory committees of the CNR
(Consiglio nazionale deIIe ricerche) in Italy, 106 are scientists. L2
experts are appointed from industry and 12 further members are co-opted.
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TOTAL
In Denmark the members of advisory
for Education, not arbrtrarily but
committees are
on a proposal
appointed by the Minister
from institutions.
(a)
(b)
(c)
(c) Alternatives to the Commission's proposal
95. The advisory committee for this programme must be constituted
differently from previous committees because the conventional structure
could jeopardize the success of the projects.
One possible solution might be as follows :
The government of each Itlember State would appoint one representative
to represent its interests;
The Commission would appoint freely four representatives drawn from
industry, five applied research scientists and three representatives
of the Commission;
On a proposal from EMBO the Commission would appoint nine basie
research scientists.
There are other possible solutions. But the important thing is to
ensure the influence of the scientists and reduce the element of national
representation.
Proqramme evaluation
96. Properly run research programmes must include a system for evaluating
their results. The Commission proposes a system of written interim reports
and a final report. These reports would be evaluated by Commission
officials and the advisory committee. This method caIIs forth the same
objections as those made under the section'Choice of Projects'. It cannot
be expected to produce an efficient evaluation of results and, considering
the level of estimated expenditure, would be highly irresponsible. It is
another reason for calling for a different composition of the advisory
committee. Alternatively, it might be possible to delegate the task of
evaluation to small committees of scientists appointed by the Commission
after consultation with the advisory committee and EMBO. In Section 5 on
Diffusion (page 14) , the Commission itself suggests the possibility of
bringing in scientific experts.
Dissemination of informatiolq
97. The Commission considers that the proper implementation of the
programrne and its harmonious evolution require a continuous flow of
information between the contractors, the Commission and third parties (for
example, the industries not directly involved in contracts).
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For this purpose :
the Commission will establish 'permanent relationships with representatives
of industries in the Member States and wiII seek permanent guidance and
advice for the preparation of programmes and the evaluation of results';
the Commission wilI'encourage through symposia, summer schools, travel
grants and research grants the establishment of permanent contact between
its contractors and researchers from non-participating industries' i
the Commission proposes 'that publicly supported laboratories participat-
ing in the Commission programme open their doors widely to industrial
research scientists and invite them to participate for short periods of
time in the work of the research groups' . New techniques and methods such
as those dealing with molecular cloning or somatic ceIl hybridization
could be transferred in this manner to the European industries.
98. The requirement for the widest possible dissemination of knowledge
about biomolecular engineering is reasonable in the context of basic
research. rn any case, academic scientists exchange information without
assistance from the Commission. However, the purpose of an applied
research programme prohibits the sort of open information policy proposed,
because it would mean that the main competitors on the world market would
have easy access to such knowledge.
99. The proposed information policy is only meaningful insofar as it aims
to familiarize biochemists in industry with techniques which have long been
standard practice in the USA and Japan. But this is not stated as one of
the aims of the programme and it would be wrong for the Community to
finance it.
100. I{oreover, the Commission's proposal underestimates the competition
e<isting at present between the industrial companies within EuroPe. The
proposed measures should be re-examined carefully to take account of these
obj ections.
Prooertv in inventions and renavment clause
101. The object of the research programme is to make European industry
more competitive. If this is to be achieved, two requirements must be met
(a) inventions must be protected by patents
(b) the Commission must have a say in how the patents are exploited.
LOZ. To prevent the premature disclosure of information which in the
interests of the contractor should remain secret, it is proposed to apply
for the execution of the programme Council Regulation (EEC No. 23AO/74\ 
'
which adopts provisions for the dissemination of information relating to
research programmes for the European Economic Community. A set of general
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rules based on the Council Regulation has been drawn up (XrIrlLO5/76) and is
used in other Commission Programmes.
Document No. XII/I05/76 sets out the rights of both the contraetor and
the Commission.
The Commission mav :
- with certain limitations disseminate, publish and use information for its
own purposes,
- reqi-re the contractor to obtain its consent before passing on information
to third Parties,
- where patentable information is passed on, require the contractor to
refrain from any action which might adversely affect the patentability
of the invention,
- apply for patents in the name of the community where the contractor
renounces that right,
- require tSat inventions be exploited strbject to conditions favourinq the
interest of the CommunitY,
- require Iicences to be granted to other contractual partners of the
Commission which have carried out related research work under the programme.
The contractor mav :
- subject to giving satisfactory reasons prevent the publication of informa-
tion from the final report where he himself renounces the right to
publish,
- use information and reports for his own purposes'
- when passing on patentable information to the Commission require that the
Commission refrain from any action which might adversely affect the
patentabilitY of the invention,
- claim as his own property both patentable and non-patentable inventions
produced or developed under the contract'
This produces a balanced relationship between the interests of the
community and those of the contractor. By providing finance for the
research, the Commission acquires a right to influence its exploitation.
In Chapter 5 of its proposal the Commission indicates a possible relaxation
of the requirements in the form of individual contracts within the frame-
work of the Council Regulation. It should only deviate from the rules laid
down in Document }.ff/LO5/76 where there is no danger to its influence over
exploitation. The commission must be able, for example, in order to safe-
guard the aim of the Programme, to prevent the sale of a patent produced
with Community money to American or JaPanese industry'
PE 65.864 /fLn.
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I03. on the other hand, rt is possible to imagine cases in which patents
may be exproited expeditiousry and smoothry in Europe in any event. rn
such cases the commission's capacity to i-nfluence exploitation has littIe
practical value.
104. In such cases the Community would be better served if the Cornmission
gave up its i-nfluence and demanded the repayment of research costs. Depend-
ing on the particular circumstances, it might require repayment of part or
aII of such costs. In its opinion the Committee on Budgets demands con-
sideration of this possibility, not least in the interests of economy.
which Ieads to an important consideration : where they extend bevond the
provision of risk capital, subsidies to industrv are irreconcilable with
the conceot of an ordered market economv.
I05. At an early st-age the Commission indicated its objections to repayment
crauses, saying that they were difficurt to appry in practice. your
rapporteur therefore points out that repayment clauses are the standard
procedure in various l4ember States for the promotion of applied research
and technology :
(a) The rtalian Fund for Appried Research gives roans with repayment
contingent on technical success. The contractor can choose between
paying the money back and keeping the results for himself or not paying
the money back and handing over the results and exploitation rights;
(b) In the event of success, 'development loans' from the Dutch Ministry
for Economic Affairs are repayable with 5% interest;
(c) The Fund for Scientific and Technical Research in France provides
industrial aid covering 5U/" of project costs but repayable in the event
of economic success.
106. Admittedly the exampres given rerate to support for projects in an
advanced state of development where it is easier to forecast economic
success than in the case of more long-term research. The ltalian procedure
described under (a) above, however, avoids problems of establishing proof
of success in that the decision Iies with the contractor. The Commission
should incorporate in the research contracts a repayment arrangement along
these lines.
VI. Infrinqement of Parliament's budqetarv powers bv the Couneil
107. In its opinion the Committee on Budgets expresses concern at the CounciI,s
practice in its decisions of fixing the scope of research programmes and the
number of posts required. This constitutes a gross infringement of
Parliament's budgetary rights. The Committee on Energy and Research endorses
the objections of the Committee on Budgets. It therefore demands the use of
the conciliation procedure,should the Council again decline to fo1low
Parliament in this matter.
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I. INTRODUCTION
1. The programme proposal presented by the Commission covers an area
of research in which Europe is 1a9gin9 behind ,Iapan and US
and in which no research has so far been conducted at Community
level i.e. using joint resources and finance.
Z. As there is sufficient basic knovrledge available in Europe but
European industry is nevertheless in danger of falling behind in gror,ring
competition with Japan and the USA, the Commission regards the present
moment as particularly opportune for the introduction of a successful
trans-frontier research and development project at Community level.
3. A research programme covering two areas, enzyme and genetic engin-
eering, is planned. The Commission has established the basis for joint
cooperation at a series of in-depth seminars and by means of other
contacts with European industry culminating in the present proposal for
a medium-term programme to be implemented as an indirect action.
II. The substance of the Commission proqrarune
4. The Commission proposal covers the field of biomolecular technology and
is aimed specifically at the control of genes and their products. The
Commission has suggested six integrated projects, the scope, technical
content and application of which can be best judged by experts of the
relevant specialist committee. A11 the projects are in the field of applied
research. While they are of considerable interest to industry and
agriculture, they involve medium and long-term research which will mainly
be carried out in university laboratories. Ttre Commission e:<pects these
projects to lead, in particular, to
- a better patents balanee-sheet for the Cornmunity,
- reductions in costs and improvements in the quality of goods,
- lourer energy consumption and, finally,
- improveil environmental protection.
The general aim is to revitalize the existing innate innovatory
capability in Europe.
5. The Commission hopes to achieve these objeetives by means of a
research progralnme which will
- bring together expertise and development opportunities in the community,
- coordinate and provide for the joint planning of various existing
projects and
- integrate protective measures against bio-hazards.
The purpose of these measures is to optirnize the productivity of the
research activities of European industry and agriculture.
- 
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III. Fundinq of the research proqranme
6. The Commission estimates the total costs for the entire foreseeable
life of the programme at just under 50 million EUA, of which 26 million
EUA is to be met from the Community budget.
i. More specifically, the prograrnme is an indirect action to be carried
out on the basis of cost-sharing agreements with private and public
organizations. This means that the Corununity will pay uP Lo 50% of the
cost of the projects listed in Annex I of the Commission document. Past
experience has shown, however, that there are occasional excepEions to
this in practice and that much higher subsidies are also approved by the
I
commission*. The latter has already indicated that a study is being
carried out on its behalf into the establishment of stricter criteria.
B. The financial record in the Commission document gives a detailed
analysis of the payment and eornmitment appropriations for staff, adminis-
tration and technical management and contracts over the period 1981-1985.
The Commission believes that coordination and secretarial work will
require the creation of six new posts, three in category A, one in category
B and two in category C.
9. The Commission will be fully responsible for implementing the pro-
grammes but will also have the support of an advisory programme committee
to help ensure that the research and development programme is carried out
as efficiently as possible. The committee will be a purely advisory
body with particular responsibili-ty for
- the selection of research units,
- Lhe integration of these research units,
- 
the appointment of project coordinators,
- the coordination of the activities of the six research groups,
- 
the regular evaluation of the progress of the research and, if necessary,
the modification of programmes,
- contacts between the Commission and European industry for the purpose
of defining new research objectives and making the optimum use of the
results obtained.
The committee will consisL of three Commission representatives and
three representatives of each Member State.
lsee the relevant discussion of the corunittee on Budgetary Control
concerning the granting of a discharge for the 1978 financial year in
the field of research, PE 62.880
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(a)
IV. Comments of the Corunittee on Budqets
10. rn the right of the above remarks, a conrparison between the new
research programme and existing indirect actions is carred for. The
table in Annex I lists aII current indirect actions, the total funding
for the duration of the prograrune and the number of posts created in
each case. This list shows that, in terms of size, the new research
programme in the fiel-d of biomolecular technology proposed by the
Commission would fall into the larger programme category and that in fact
only the JETadfusicnprogramme, the energiy research programmes and the
radiation protection Progralnme are larger. It would aecount for almost
5% of the total appropriations for indirect actions. The numbers of
staff required to coordinate and administer the prograrnme, are commen-
surate with this.
Considerable research efforts are also be.ing made in some c-ases ir:
thc Communitl' Menrber StaLes. It is, hor*ever, very diffleult to
determine the total amount of research expenditure in the Membcr States
for the purpose of comparison with the proposed Commission programne.
11. rt is not for the committee on Budgets to assess the need for and
usefurness of a prograrnme of the kind suggested by the commission. The
Progralnme is in any case so complex and specialised that it eequires the
aesistance of erperts to judge it. The conunittee on Budgets proposes, there-
forQ' to concentrate only on the financial aspects and adrninlstratLve prcblans.
Consideration of the financial, administrative and organizat.ional
aspects nevertheless inplies some assessment of the effectiveness and
viability of the progralnme and of the staffing implications. The eomments
of the Comxnittee on Budgets are set out below:
Coneentration and efficient use of resources
12. As a general rule, aDY pooling of both financial and intellectual
resources in the European community is to be welcomed. As the commission
itself points out, 'the budget needed for initiating and bringing to term
a detailed and important research action in molecular biology tends,
nowadays, to exceed the possibilities of single institutes and, in certain
cases, those of smarl nations,.l
1ro". L-75o/79, page 7
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13. rn the light of the information given alorrc, il i" possible to situate
the lever of expenditure proposed by the commission in the overarl context
of other existing research projects. As the co*nittee on Budgets must
always ensure that appropriations are used as efficiently as possible ancl
that they are not spread too thinly over a wide range of different activi-
ties, the question of the order of priorities for Community research must be
considered. The Commission advances arguments of a general nature such as
'the optimization of food production', 'optimization of the competitiveness
of European industries', 'improvement of life in society,, and finarry
'coordinating and stimulating research directly appried to ... heatth
protection, preservation of the environment and the use of solar
'I
energy'- to justify launching the new research project.
L4. Finally, there are economic arquments and the Commission attempts
to cover this aspect by drawing up a patents barance-sheet. The figures
relating to patents in individual countries given on page 8 of the
Commission document, must be treated with caution as it appears
that these individual patent applications are not comparabre and the
Community is well placed in the middle ranks of the compatable countries
when the patent applications of individual Ivtember States are
added t,ogether.
15. It is primarily for the Committee on Energy to say whether further
expansion of Community research in this area is desirable. Even if the
answer to this question is in the affirmative, there is still the matter
of whether the six projects proposed by the commission actuarly
represent the best possible focus of research and optimum use of
available Conununity funds. According to ttre Commission, the projects
are designed to take account of the specific objectives of agriculture
and industry. rn this context care must also be taken to ensure that
EuroPean industry is not indirectly subei/riz€.l hrith the Conununity
financing projects which wouLd otherwise be carried out by industry
acting on its ovrn initiative. rn other nords, only those medium and
lonq-term proqrammes should be promoted \^rhich, as well as having some
prospects of success, would not be carried out bv industrv or aqriculture
without appropriate encouraqement or incentives.
(b) Savinqs on expenditure, repavment
16. The possibility of industry repaying subsidies in cases where the
results of research are successfully applied should therefore be
considered.
on page 13 of the proposal the Commission states that 'the invention,
patentable or not, shall belong to the contraetor if he so desires'.
Ico**i""ion proposal, paragraph 3.2.4, page I0.
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17. In pursuing the aim of a repayment approach, detailed criteria
would have to be laid down specifying under what circumstances and at
what time repayment wouid be made. The Commission is asked to incorporate
a repayment clause in the regulation and in individual contracts to be
concluded by it in cases where the results of the research are used for
industrial or commercial purposes and earn profits. This aspect should
be dealt with independentl-y from the lodging of patent applications.
18. The Committee on Budgets realizes that it is extremely difficult to
define cri-teria in a legally water-tight manner and to ascertain the
possible benefits of a project. However, the commission should do
everythingpossibletobenefitultimatelyfromanycommerciale><ploitation
oftheresultsofcomnunityorganisedresearchbywayofpalrmentofroyalty
fees by commercial interests benefitting from such research' which income
couLd be used to finance new research programmes. rf the commission is
unabre to obtain refunds on payments correspondirg to commerciar profits'
because of a lack of authority to enforce the corresponding decisions,
itwouldbeappropriatetoconsiderwhethersufficientPressurecouldbe
broughttobearbyrefusingtoconcludefurttrercontractswiththose
companies.
concerning this idea of refund or share of royalties' the ECSC General
provisions applicable to research agreements give a suitable precedent' as
Iaid down in Annex IV of the Internal Provision's on the execution of the
operationalbudgetinArticlesS-12.ParticuJ.ar}yinArticle12,a
detaileddefinitionof,,shareofroyalties'.ismade.TheCommissionis
askedtoprovideforaroyaltiesclauseintheregu}ationinordertolay
down, where appropriate, provisions in individual contracts'
(c) Coordination
19. A further very important aim of this programme and indeed of any
pooling of Community activities, must be to coordinate in a useful way
the research activities of the Member States. Your draftsman does not
believe that this must always necessarily resurt in a corresponding
concentration of research centres. The generar idea should be to
Promote or organize a system of cooperation within the Community so as
to improve the overall effectiveness or optimize the productivity of
research. This, if it were aehieved, would help the Community to
compete more successfully with eountries such as the USA and Japan.
(d) Administration and orqanization 
- advisorv proqramme committee
20. As far as the administration and organization of the work is concerned,
it has already been pointed out that the Commission would assume fuIl
responsibility for implementing the projects. The corunittee on Budgets
can agree to the setting up of an advisory committee containing represen-
tatives of the Member Statespaovided srch body reor:ld be purely consuttative.
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21.t' ltris raises once again the question of the real role of
programme committees. The Committee on Budgetary Control has already
dealt extensively with the problem of administrative committees and advisor-v
programme committees in the course of its work on preparing the discharge
for the 1978 financial year. It feels that 'these bodies are useful
and important, particularly for ensuring scientific advice and coordination
between the Community ancl the Member States' . I
22. Nevertheless, it must be re-emphasized that the Commission should
resist any pressure from these committees ajrned at influencing decisions
for which the former is eompetent. It must also decisively oppose the
disruption of programmes by Member States withdrawing once interesting
results begin to emerge and continuing the research at national 1evel.
The Commission should be urged to report such occurrences immediately to
the Parliament or its Corunittee on Budgetary Control.
(e) Staff
23. As far as staff are concerned, the Committee on Budgets
recognizes its limited capacity to iudoe whether the Commission has
sufficient experts to coPe
with such a specialized field and supervise the research work or whether
three net, A category officials are indeed essential. It points out,
bouever,that a sufficient number of experts were available to draw up the
progranune in the first place and conduct the PreParatory seminars and
contacts with industry. The Committee on Budgets therefore calls on the
relevant expert committee and on the Commission to consider carefully
whether any experts already on its staff could be seconded to this project.
The Committee on Budgets consequently takes note of the request for posts
subject to the usual provisos.
(f ) Fixinq of e)<penditure
24. The committee on Budgets is once again forced to point out that it
cannot agree to the Council fixing a ceiling on expenditure for the
duration of the five-year progranune.
(1)PE 62.B}o/rev., page 22
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25. Although a satisfactory arrangement was reached some time ago with
the Commission regarding the expenditure estimates in Article 2 of the
regulations (the present proposal for a regulation also contains this
text), the council persists in regularly 'fixing'the volume ofappropriatiorrs
and the number of posts for research programmes in the regulations it
1adopts-. This constitutes a presumptious but illegat violatlon of the
budgetary povrers of the European Parliament in its capacity as one of tle two
arms of the budgetary authority, and shows the Council's disegardfcrhrdftalf
procedures. A provision which satisfies the Parliament as far as the
research field is concerned is to be found in the Commission,s proposal
for a regulation amending the Financial Regulation of 21 December Lg772
but the Council exeluded this aspect from its decision3. This problem
rnust be solved as a matler of urgency in the proposed revision of the
Financial Regulation to be carried out this year. But even before tltat,
the Council sirould at. .l-ast agree to such an arrangemettt when
adopting this new research prograflune. The Committee on Budgets urges the
Committee on Energy to request that, the conciliation procedure be initiated,
if the Council refuses yet again tc go along with Parliament in this
matter. If the Council refuses such eonciliation, the Committee on
Budgrets may find itself reluctantly connpelled to recorunend that
Parliament use the budget procedure to bloek all appropriat,ions for a
research programme of this kind (non-eompulsory expenditure).
CONCLUSIONS
The cornmittee on Budgets approves the commj.ssion proposal for a
regulation while urging the commi'ttee responsible, the Committee on Energy
and Research, to make final approval by Parliament conditional on clarifi-
cation of the following point-s:
(a) Does the expansion of Community research in this field not mean that
resources are being too thinly spread, or in other words that a
Progralnme of this type upsets the Community's research priorities?
(b) Would it be possible for the Commission to use existing specialized
staff for this research project, thus in effect reducinE the
requirement for new staff?
lsee the latest Council decisions on research programmes for radiation
protection, the management and storage of radioactive waste and medicine
and public health, OJ L 78, 25 March 1980, Pages L9-25
2S"n 
"*"ndments to Article BB in the Commission proposal, OJ C 160,6 July L978, Page 1-1
3ot l, 160, 28 June L97g, page r
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In this matter the Committee on Budgets favours:
- efficient and concentrated use of aII the research appropriations
available to the CommunitY,
- meeting staff reguirements by transfer of existing personnel.
If the Committee on Energy and Research also decided to approve
the proposal, the Committee on Budgets would like to see the following
points included in the resolution:
- 
Approves the commission proPosat, particularlv with a view to
achievinq the efficient coordination of individual national research
activities at community level and hence arrive at a sensible
concentration of research expenditure in this field;
- Urges the Commission in this connection to give first priority to
promoting or financing those medium and long-term researctr projects
which, despit-e their likely success, would nevertheless not be
carried out by industry and agriculture without appropriate
encoura:qement or incentives ;
- 
Calls for the conciliation procedure to be initiated if the Council
presumes, once again, to infringe the budgetary Powers of the
European Parliament by 'fixing' the level of appropriations and
number of posts in the text of the regulation for the duration of
this research programme and gives notice that Parliament may find
itself compelled, if this legitimate wish is ignored, to bloek
alI the appropriations entered for this purpose in the appropriate
budget.
- Reiterates its view that aIl the advisory committees active in the
research sector, including the advisory programme committee provided
for in this particular programme, should have a purely advisory role
and calls upon the Commission to inform the Parliament without delay
of any overstepping of this authority which has already taken place
or is liable to occur;
- Reguests the Commission to incorPorate a royalties clause in the
research contracts planned with industrial undertakinqs;
- Reguests the Commission to incorPorate the following amendments
in its proposal in accordance with Article 119, second paragraph,
of the EEC TreatY.
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TE\-T PROPoSEI) rlY THI COMlllSSloN oF
THE EUROPE.\N ('Oi\ITIUNITIES
\\tt Nl)Et) I t\ I
Preamble and recitals unchanged
Article I unchanged
n e w Articl-12
l.The Community shall promote the
research projects described in Annex
A as an indirect action by means of
cost-sharing contracts. hcrrision stra II
bna& frrepayment of a part of the
contrjlution if the research proves
successful and is utilized industrially
or commercially and,/or leads to the
lodging of a corresPonding Patent
application and the subsequent award
of licences.
2. fhe average contribution shall not
crceed 5O%. In ealculating the
Cormunity' s contribution towards apartieular projeet, aceount shall be
taken of all other subsidies whichhave been granted or are ercpected.
3. The Commission shaII negotiate and
conclude the necessary contracts. For
this purpose, it shal} draw up a standard
contract defining the rights and oblig-
ations of each Party, irrJ,tdnq rftae :frqPrjsgs
conditions and procedures for the possible
repayment of amounts contributed.
Article 2 becomes Article 3
Article 3 becomes Article 4
Article 4 becomes Article 5
Artiele 5 becomes Article 6
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ANNEX
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Item Heading Staff for L979 Programme Decision
A B c D Total Date Effective
f rorn
Durationl ceiling:
EUA
Staff
a;rp=ove,1
3 350
33s1
3 351
3352
3353
33s4
3355
3356
3357
3359
3361-
3362
3363
3364
3365
337 0
3380
3381
Training
Fusion and plasma PhYsics
JET
Biology and health Protection
Reference materials and nethodr
Environment
Amendment
The plutonium cycle
Amendment
Management and storage of
radioactive waste
Energy research and develoPmelst Programme
2nd programme
Decommissioning of nuclear
power stations
Primary raw materials
Long-term forecasts and
evaluations
Water-cooled thermal reactor
safety
Uranium ore prosPecting and
processing
Recycling of wastePaPer and
board
Council resolution on nuclear
safetY
BR2 reactor
other research staff made
available
l2I tqlzoln,sl Ilot,l"lz
i
n! rz
Ii',t,lsl'lz
Il2
Il1
l4
Ileln
I
I
I
l,
[.
l'
2
35
44
L2
I
1
tl
1
Ilt
I
Il7
It-irI1
:
10
;
3
1
1
2
2
3
11
10
4
3
1
I
1
6
LL2
L25
64
13
10
3
4
27
34
2
I
10
2t.L2.75 i
25 .O3 .7 6
30.o5.78
15.03.76
9.LO.79
15.03.76
9.LO.79:
L7 .L2.74 '
10.10.78
26.O5.75 |
22.04.75
LL.09.79
27 .03 .7 9
6.O3 .7I
25.O7 -78
27 .03 .7 9
6.O3.74
L7 .O4.74
22 -O7 .75
27.LL.73
24.04 .7 4
2r.03 .7 4
2s.04.7 4
L.OL.77
L.OL.76
1.0I. 7 8
L.OL.7 6
t.o]-.'19
L-OL,.16
I.01.7s
r. 01.75
L.OL.75
L. o'7 .75
L.O7.79
L. OL.'7 9
1.01.78
L7.O8.78
L.OL.7 9
L.CL.7A
L.OL.7A
26
2L (c .E .A. )
'c. r. K. )
I Luxatom )
years
years
years
years
years
years
years
years
years
years
years
years
years
years
years
years
years
-
4
5
L2
5
4
5
4
5
5
4
4
5
4
5
5
3
3
6
113
150
68
l4
10
27
34
3
I
10
30
L3
c,
1
4. 600.00o 
I
124. oOO. ooo 
Ito2 
-400.000 I
3e. ooo. ooo I
I10. 3OO. OOO I
15. OOO . OO0 i
20. 8oo. ooo I
4. 5oO. ooo I
4.75o.OOOl
le. 160. ooo i
59. OO0. OO0 ;
i
I
105. OOO. 000 I
I
4.700.000 I
18. OOO . OoO I
4.4OO.oOo I
6. 300. ooo i
I
3.000. ooo I
I
I
2-900.0o0 |
i
i
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Item H€adin9 Staff for L979 IProgramme Decision
ABCDTotal Date Effect ive
from
Duration Ce il-ing :
EUA
Staff I
approved I
3371-O
3371-1
337 l-2
337 r-3
337 L-4
3371-5
Processing and utilization
of sewage sludge
Gro\^rth of large urban
concentrations
tledical research I -
- 
abnormalities
- cellular ageing
- oxygenation
Food technology I
Analysis of organic micro-pollutants in water
Physicochemical behaviou r
atmospheric pollutants
of
1_1
1-1-2
27
7
09.77
02.74
L3.A2.7A
L3.O2.7A
L3 
-O2.7A
20.02.78
9.10-78
9.10.78
L9-LO.77
17 -o2.78
1.01. 78
1.01.78
L.OL-7A
25 .O2.7 I
4 - LL.7A
4.LL.78
3
2
years
years
years
years
years
years
years
years
3
4
4
3
4
4
140. 000
200. 000
850. 000
400. 000
360. OOO
250. OOO
4BO. 000
500. ooo
-i
_t1l
,l
Total: 551.99O.0O0
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PROTECTI ON
Letter from the chairman to Ivlrs WALZ, chairman of the Committee on Energv
and Research
25 APril, 1980
Dear l,lrs Vlalz,
At its meeting of 25 April f980I the Committee on the Environment,
public Health and Consumer Protection considered the proposal from the
Commission of the European Communities to the Council for a multiannual
Community prograrune of research and development in blomolecular engineer-
ing (indirect actlon: 1981-1985) (Doc. L-750/'19) on which it was asked for
its opinion on I2 Februari' I980.
It was emphasisect that a Commttnity biotechnologl' Progranme could
fiI1 scnre of thc qaps in the scientific field in thc Community an(i boost
th.i Member States' efforts in this scctor.
Tire pro$rarnrne is concerned in
coorij.nation of a range of applied
tochn::Iog1' cf suitable host-vector
rrrlpor-udnt practical problems which
f ore:-gn DNA.
particular with the stimulation and
research for the development of enzyrne
systems and also for the solution of
prevent the control of expression of
Tlie Cornmunity is to rnake provision iri the I98l budget for about half
the estimated financial requiremerrt- of this indirect action, which is based
o1 Art.cle 235 of tlie EEC Trearyr and which provi.des for the setting up of
an ACvisor].Cornmitlee to asslst the Commissioll in its management task.
tritir the harmc.nious developmerii- of recFulations and Protective measures
which new techniques should always be accompanied by as soon as they are
introducecl, it offers innovative potential as regards application in agri-
culture and industry and Lhe protection of mankind and his environment.
Consiclering that the bromolecular engineering Progra[une actually meets
a need anrl as such has been favourably assessed. by the Scientific and
Techni.cal Research Committ-ee (CREST), the Comnit-tee on the Environment,
Public tsea1th and Consumer Protection hereby expresses its complete
approval with one abstention.
Please regard this document as the opinion of the CoNnittee on the
Environment, Pr"iblic tlealth and Consumer Protection.
Yours sincerely,
(sgd) Kenneth COLLINS
Chairman
lPresent: Mr Alber, Vice-Chairman; Mr Adam , Mr Ceravolo, Mrs Fuillet,
Mr Forth, Mr Ghergo, l'lrs Maij-Weggen, Mr Muntingh, Mr Newton Dunn,
Mrs Scrivener, Mr Sherlock, Mrs Spaak, Mrs Squarcialupi
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OPINION OF THE COMMITTEE ON ECONOMIC AND ITIONETARY AFFAIRS
Letter from the chairman to Mrs WALZ, chairman of the Committee on
Energy and Research
27 February 1980
Dear l,lrs WaIz,
At its meeting of 2L February 1980 the Committee on Economic and
Monetary Affairs considered the proposal from the commission to the
council for a murtiannuar community programme of research and deverop-
ment in biomolecular engineering (indirect action 1981-1985).
WhiIe acknowledging the undeniable economic importance attaching
to the imprementation of such a research programme in this field, the
members of the committee felt that they lacked the technical resources
needed for making a worthwhile appraisal of the quality of the
programme envisaged.
Consequently, the committee decided it would be preferable not to
offer an opinion on the document in question.
f therefore ask you to regard this letter as formal notification
of the committee's decision to decline to deliver an opinion in this
instance.
(sgd) Jacques L. J. DELORS
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